Ben M. Lomaestro

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists

Michael J. Rybak, Ben M. Lomaestro, John C. Rotscahfer et al. · Clinical Infectious Diseases · 2009 · 799 citations · Full text

Antibiotic Adjuvant, Pharmacotherapy, Antimicrobial Chemotherapy +21

Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity

Thomas P. Lodise, Ben M. Lomaestro, Jeffrey Graves et al. · Antimicrobial Agents and Chemotherapy · 2008 · 577 citations · Full text

Renal Pathology, Pharmacotherapy, Antimicrobial Chemotherapy +23

Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia Treated with Vancomycin

Thomas P. Lodise, Jeffrey Graves, A. Evans et al. · Antimicrobial Agents and Chemotherapy · 2008 · 551 citations · Full text

Mrsa Culture, Mrsa Bacteremia, Antibiotic Resistance +16

Relationship between Initial Vancomycin Concentration‐Time Profile and Nephrotoxicity among Hospitalized Patients

Thomas P. Lodise, Nimish Patel, Ben M. Lomaestro et al. · Clinical Infectious Diseases · 2009 · 544 citations

Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy

Thomas P. Lodise, Ben M. Lomaestro, George L. Drusano · Clinical Infectious Diseases · 2007 · 526 citations